What is NDC 69751-101?

69751-101 is the product NDC for Phexx, Lactic acid, L- 90 mg/5g + 2 more ingredients gel, listed with the FDA by Evofem, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Phexx (Lactic acid, L-, citric acid monohydrate, and potassium bitartrate).

What is the active ingredient?

Lactic acid, L-, Citric acid monohydrate, Potassium bitartrate.

Evofem, Inc., NDC labeler code 69751. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Phexx?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Phexx NDC 69751-101 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)69751-101Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69751-0101Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69751-101-12	69751010112	12 APPLICATOR in 1 BOX (69751-101-12) / 5 g in 1 APPLICATOR (69751-101-01)Marketed from Sep 1, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Phexx
Generic name (nonproprietary): lactic acid, l-, citric acid monohydrate, and potassium bitartrate
Active ingredients: Lactic acid, L- — 90 mg/5gCitric acid monohydrate — 50 mg/5gPotassium bitartrate — 20 mg/5g
Dosage form: Gel
Route: Vaginal
Labeler: Evofem, Inc.NDC labeler code 69751
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 208352
Marketing start: Aug 1, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Acidifying Activity (Mechanism)Calcium Chelating Activity (Mechanism)Decreased Coagulation Factor Activity (Physiologic effect)
Identifiers: Product ID 69751-101_7c67c2d2-59fd-423a-b446-a528f43a0916SPL ID 7c67c2d2-59fd-423a-b446-a528f43a0916SPL set ID 14b01a15-9b47-4be3-bb2e-a2010eab429eRxCUI 2385348, 2700386UNII F9S9FFU82N, 2968PHW8QP, NPT6P8P3UU
Pharmacologic class: Anti-coagulant; Calculi Dissolution Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N469751010112 followed by a unit qualifier and the quantity

Package 69751-0101-12. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 2, 2025.

Indications (excerpt from the label)

PHEXX is indicated for the prevention of pregnancy in females of reproductive potential for use as an on-demand method of contraception. PHEXX is a combination of lactic acid, citric acid, and potassium bitartrate indicated for the prevention of pregnancy in females of reproductive potential for use as an on-demand method of contraception. ( 1 ) Limitations of Use: PHEXX is not effective for the prevention of pregnancy when administered after intercourse. Limitations of Use PHEXX is not effective for the prevention of pregnancy when administered after intercourse [ see Dosage and Administration (2.1) ].

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 69751-101

What is NDC 69751-101?: 69751-101 is the product NDC for Phexx, Lactic acid, L- 90 mg/5g + 2 more ingredients gel, listed with the FDA by Evofem, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Phexx (Lactic acid, L-, citric acid monohydrate, and potassium bitartrate).
What is the active ingredient?: Lactic acid, L-, Citric acid monohydrate, Potassium bitartrate.
Who is the labeler?: Evofem, Inc., NDC labeler code 69751. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Phexx?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under NDA 208352

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 208352
Product	Strength	Form · route	Labeler	Product NDC
Phexxilactic acid, l-, citric acid monohydrate, and potassium bitartrate	Lactic acid, L- 90 mg/5g + 2 more ingredients	GelVaginal	Evofem, Inc.	69751-100